Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Allergan Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (16)
Australian public assessment report (AusPar) (1)

Date

(-) 2016 (17)
2023 (3)
2019 (18)
2018 (2)
2017 (26)
2014 (1)
2013 (1)
2012 (1)
2011 (3)
2010 (1)

Search

Filters applied:

2016

Clear all

Sponsor content

17 result(s) found, displaying 11 to 17

Allergan Australia Pty Limited - Juvederm ULTRA PLUS with lidocaine - Tissue reconstructive material, biological Cancelled under s41GL(d) of the Act

1 December 2016

Cancellation by sponsor

Requested by Allergan Australia Pty Ltd
Juvederm 18 - Tissue reconstructive material, biological Cancelled under s41GL(d) of the Act

28 November 2016

Cancellation by sponsor

Requested by Allergan Australia Pty Ltd
Juvederm 24 - Tissue reconstructive material, biological Cancelled under s41GL(d) of the Act

28 November 2016

Cancellation by sponsor

Requested by Allergan Australia Pty Ltd
Juvederm 30 - Tissue reconstructive material, biological Cancelled under s41GL(d) of the Act

28 November 2016

Cancellation by sponsor

Requested by Allergan Australia Pty Ltd
Inamed Pty Ltd T/A Inamed Aesthetics Pty Ltd - Juvederm Ultra - Tissue reconstructive material, biological Cancelled under s41GL(d) of the Act

28 November 2016

Cancellation by sponsor

Requested by Allergan Australia Pty Ltd
Inamed Pty Ltd T/A Inamed Aesthetics Pty Ltd - Juvederm Ultra Plus - Tissue reconstructive material, biological Cancelled under s41GL(d) of the Act

28 November 2016

Cancellation by sponsor

Requested by Allergan Australia Pty Ltd
AusPAR: Dexamethasone

4 November 2016

Australian public assessment report (AusPar)

Australian Public Assessment Report for dexamethasone

Pages

First page
Previous page
Page 1
Current page 2

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.